AR071104A1 - Metodo para determinar una proteina de haemophilus parasuis que comprende un determinante antigenico de reaccion cruzada - Google Patents
Metodo para determinar una proteina de haemophilus parasuis que comprende un determinante antigenico de reaccion cruzadaInfo
- Publication number
- AR071104A1 AR071104A1 ARP090101114A ARP090101114A AR071104A1 AR 071104 A1 AR071104 A1 AR 071104A1 AR P090101114 A ARP090101114 A AR P090101114A AR P090101114 A ARP090101114 A AR P090101114A AR 071104 A1 AR071104 A1 AR 071104A1
- Authority
- AR
- Argentina
- Prior art keywords
- determining
- cross
- antigen
- protein
- reactive
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5052—Cells of the immune system involving B-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Abstract
Se suministran composiciones y métodos para determinar inmunologicamente moléculas de reaccion cruzada que comprenden el determinante antigénico de reaccion cruzada, en particular para determinar las proteínas que comprenden los determinantes antigénicos de reaccion cruzada, en particular para determinar las proteínas que son de reaccion cruzada con base en selecciones serologicas que utilizan los exposiciones inmunologicas secuenciales a un animal, que incluyen determinar las proteínas reaccion cruzada de H. parasuis. También se suministran composiciones, vacunas y equipos que utilizan las moléculas para diagnosticos y métodos para evitar o tratar una enfermedad, trastornos, afeccion o síntomas de estos asociados con los agentes infecciosos, en particular microorganismos infecciosos, en particular para prevenir o tratar una enfermedad, trastorno, afeccion o síntomas de estos asociada con la afeccion por H. parasuis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4026008P | 2008-03-28 | 2008-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR071104A1 true AR071104A1 (es) | 2010-05-26 |
Family
ID=40757034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090101114A AR071104A1 (es) | 2008-03-28 | 2009-03-27 | Metodo para determinar una proteina de haemophilus parasuis que comprende un determinante antigenico de reaccion cruzada |
Country Status (15)
Country | Link |
---|---|
US (2) | US9046528B2 (es) |
EP (1) | EP2262828B1 (es) |
KR (1) | KR101647159B1 (es) |
CN (1) | CN101981052B (es) |
AR (1) | AR071104A1 (es) |
BR (1) | BRPI0909493A2 (es) |
CA (1) | CA2719041C (es) |
CL (1) | CL2009000768A1 (es) |
CO (1) | CO6290771A2 (es) |
ES (1) | ES2551699T3 (es) |
HK (1) | HK1149770A1 (es) |
MX (1) | MX2010010614A (es) |
PL (1) | PL2262828T3 (es) |
RU (1) | RU2555530C2 (es) |
WO (1) | WO2009118273A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009118273A1 (en) | 2008-03-28 | 2009-10-01 | Novartis Ag | Compositions, methods and kits |
WO2011131789A1 (en) * | 2010-04-23 | 2011-10-27 | Intervet International B.V. | A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |
CN102399724B (zh) * | 2011-11-08 | 2013-01-02 | 山东省农业科学院畜牧兽医研究所 | 一种副猪嗜血杆菌lc株及其应用 |
CN104306964B (zh) * | 2014-11-12 | 2017-10-10 | 四川农业大学 | 重组副猪嗜血杆菌免疫保护性抗原HbpA2的用途及用其制备的亚单位疫苗 |
CN104404056B (zh) * | 2014-11-12 | 2017-07-18 | 四川农业大学 | 一种重组副猪嗜血杆菌免疫保护性抗原HbpA2及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6713071B1 (en) * | 1998-10-22 | 2004-03-30 | Pfizer Inc. | Proteins from actinobacillus pleuropneumoniae |
US20090087878A9 (en) | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
RU2268933C1 (ru) * | 2004-04-21 | 2006-01-27 | Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ ВНИИЗЖ) | ШТАММ Haemophilus parasuis СК-1 - ВОЗБУДИТЕЛЬ ГЕМОФИЛЕЗНОГО ПОЛИСЕРОЗИТА СВИНЕЙ ДЛЯ ИЗГОТОВЛЕНИЯ ДИАГНОСТИЧЕСКИХ И ВАКЦИННЫХ ПРЕПАРАТОВ |
WO2006132893A2 (en) * | 2005-06-07 | 2006-12-14 | Buck Institute For Age Research | Sialic acid abc transporters in prokaryotes therapeutic targets |
WO2009118273A1 (en) * | 2008-03-28 | 2009-10-01 | Novartis Ag | Compositions, methods and kits |
CA2779515A1 (en) * | 2009-11-04 | 2011-05-12 | Simone Oliveira | Haemophilus parasuis polypeptides and methods of use |
-
2009
- 2009-03-20 WO PCT/EP2009/053281 patent/WO2009118273A1/en active Application Filing
- 2009-03-20 US US12/934,654 patent/US9046528B2/en active Active
- 2009-03-20 ES ES09725988.1T patent/ES2551699T3/es active Active
- 2009-03-20 PL PL09725988T patent/PL2262828T3/pl unknown
- 2009-03-20 BR BRPI0909493A patent/BRPI0909493A2/pt not_active Application Discontinuation
- 2009-03-20 CN CN200980111336.2A patent/CN101981052B/zh active Active
- 2009-03-20 MX MX2010010614A patent/MX2010010614A/es active IP Right Grant
- 2009-03-20 CA CA2719041A patent/CA2719041C/en active Active
- 2009-03-20 EP EP09725988.1A patent/EP2262828B1/en active Active
- 2009-03-20 KR KR1020107024065A patent/KR101647159B1/ko active IP Right Grant
- 2009-03-20 RU RU2010143903/10A patent/RU2555530C2/ru active
- 2009-03-27 CL CL2009000768A patent/CL2009000768A1/es unknown
- 2009-03-27 AR ARP090101114A patent/AR071104A1/es unknown
-
2010
- 2010-09-27 CO CO10119116A patent/CO6290771A2/es active IP Right Grant
-
2011
- 2011-04-07 HK HK11103550.3A patent/HK1149770A1/xx not_active IP Right Cessation
-
2015
- 2015-04-27 US US14/696,904 patent/US10261092B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CO6290771A2 (es) | 2011-06-20 |
US9046528B2 (en) | 2015-06-02 |
WO2009118273A1 (en) | 2009-10-01 |
US10261092B2 (en) | 2019-04-16 |
KR20100139096A (ko) | 2010-12-31 |
ES2551699T3 (es) | 2015-11-23 |
CN101981052B (zh) | 2014-11-26 |
EP2262828B1 (en) | 2015-09-30 |
CA2719041A1 (en) | 2009-10-01 |
RU2555530C2 (ru) | 2015-07-10 |
RU2010143903A (ru) | 2012-05-10 |
CL2009000768A1 (es) | 2011-07-01 |
MX2010010614A (es) | 2010-11-09 |
CN101981052A (zh) | 2011-02-23 |
PL2262828T3 (pl) | 2016-03-31 |
US20150293118A1 (en) | 2015-10-15 |
EP2262828A1 (en) | 2010-12-22 |
CA2719041C (en) | 2016-08-16 |
BRPI0909493A2 (pt) | 2017-11-07 |
US20110014225A1 (en) | 2011-01-20 |
KR101647159B1 (ko) | 2016-08-09 |
HK1149770A1 (en) | 2011-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121672T1 (el) | Αντισωματα που προσδενουν τα il-17a και il-17f | |
CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
CY1126083T1 (el) | Μοντελα τρωκτικων και θεραπευτικα μορια | |
CY1125133T1 (el) | Πρωτεϊνες συνδεσης αντιγονου υποδοχεα a il-17 | |
AR053711A1 (es) | Combinacion de vacunas para circovirus porcina y helicobacter y metodos de utilizacion | |
CY1118880T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
CO6260103A2 (es) | Composiciones que comprenden antigenos neumococidos | |
TN2014000120A1 (en) | Cd27l antigen binding proteins | |
AR083747A1 (es) | Anticuerpos anti-il-23 | |
CY1115147T1 (el) | Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17 | |
AR057224A1 (es) | Moleculas de anticuerpo que tienen especificidad para la il- 6 humana | |
NO20072253L (no) | Forbedrede vaksiner | |
CR20130016A (es) | ANTICUERPOS PEPTIDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
EA201171060A1 (ru) | Молекулы антител, обладающих специфичностью к человеческому ох40 | |
AR071104A1 (es) | Metodo para determinar una proteina de haemophilus parasuis que comprende un determinante antigenico de reaccion cruzada | |
CO6210756A2 (es) | La proteina linfopoyetina estromal timica canina y usos de la misma | |
CO6400232A2 (es) | Proteína de enlace al receptores cgrp humano | |
EA201291105A1 (ru) | Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора | |
AR077611A1 (es) | Metodo y conjunto de elementos ( kit) para tratar la adiccion a la nicotina. combinacion. uso. | |
CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
RU2014127714A (ru) | ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile | |
GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
CL2021002727A1 (es) | Vacuna con subunidades del vfpc | |
RU2015106916A (ru) | Полипептиды clostridium difficile в виде вакцины | |
AR087654A1 (es) | METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |